These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9122323)

  • 1. Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.
    Brasić JR; Barnett JY
    Psychol Rep; 1997 Feb; 80(1):163-70. PubMed ID: 9122323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychopharmacology of autistic disorders].
    Poustka L; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2007 Mar; 35(2):87-94. PubMed ID: 17608278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of haloperidol and valproate in children with Sydenham chorea.
    Ronchezel MV; Hilario MO; Forleo LH; Len CA; Terreri MT; Vilanova LC; Sole D
    Indian Pediatr; 1998 Dec; 35(12):1215-8. PubMed ID: 10216698
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief report: haloperidol treatment of trichotillomania in a boy with autism and mental retardation.
    Ghaziuddin M; Tsai LY; Ghaziuddin N
    J Autism Dev Disord; 1991 Sep; 21(3):365-71. PubMed ID: 1938782
    [No Abstract]   [Full Text] [Related]  

  • 6. Dyskinesias subside off all medication in a boy with autistic disorder and severe mental retardation.
    Brasić JR; Barnett JY; Aisemberg P; Ahn SC; Nadrich RH; Kaplan D; Ahmad R; Mendonça Mde F
    Psychol Rep; 1997 Dec; 81(3 Pt 1):755-67. PubMed ID: 9400068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid for Kleine-Levin syndrome.
    Crumley FE
    J Am Acad Child Adolesc Psychiatry; 1997 Jul; 36(7):868-9. PubMed ID: 9204661
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiating children with attention-deficit/hyperactivity disorder, conduct disorder, learning disabilities and autistic spectrum disorders by means of their motor behavior characteristics.
    Efstratopoulou M; Janssen R; Simons J
    Res Dev Disabil; 2012; 33(1):196-204. PubMed ID: 22093665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validity of psychiatric diagnoses: the case of 'specific' developmental disorders.
    Dyck MJ; Piek JP; Patrick J
    Res Dev Disabil; 2011; 32(6):2704-13. PubMed ID: 21705192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staring episodes in children with developmental disorders: epilepsy or behaviour?].
    Bos MJ; de Weerd AW; Hagebeuk EE
    Ned Tijdschr Geneeskd; 2011; 155():A2473. PubMed ID: 21447202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders.
    Hilty DM; Rodriguez GD; Hales RE
    J Neuropsychiatry Clin Neurosci; 1998; 10(3):365-6. PubMed ID: 9706547
    [No Abstract]   [Full Text] [Related]  

  • 13. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of valproic acid monotherapy on behavior and cognitive performance of children with idiopathic generalized epilepsy].
    Schmidt A; Darius J; Brosz M; Roth N; Meyer FP; Kroker S; Wien F; Brett B
    Z Kinder Jugendpsychiatr; 1995 Sep; 23(3):161-70. PubMed ID: 7571875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-induced hypomania in Asperger's disorder.
    Damore J; Stine J; Brody L
    J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):248-9. PubMed ID: 9519626
    [No Abstract]   [Full Text] [Related]  

  • 17. Confounding diagnoses in the neurodevelopmental disabilities population: a child with hearing loss, absence epilepsy, and attention-deficit hyperactivity disorder (ADHD).
    Lance EI; Shapiro BK
    J Child Neurol; 2013 May; 28(5):645-7. PubMed ID: 22761401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Landau-Kleffner and autistic regression: the importance of differential diagnosis].
    Ribeiro KM; Assumpção FB; Valente KD
    Arq Neuropsiquiatr; 2002 Sep; 60(3-B):835-9. PubMed ID: 12364957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism -- experiences in a tertiary care hospital.
    Kalra V; Seth R; Sapra S
    Indian J Pediatr; 2005 Mar; 72(3):227-30. PubMed ID: 15812118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
    Lensing P; Klingler D; Lampl C; Leboyer M; Bouvard M; Plumet MH; Panksepp J
    Acta Paedopsychiatr; 1992; 55(3):169-73. PubMed ID: 1414352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.